![Cancers | Free Full-Text | TLD1433 Photosensitizer Inhibits Conjunctival Melanoma Cells in Zebrafish Ectopic and Orthotopic Tumour Models Cancers | Free Full-Text | TLD1433 Photosensitizer Inhibits Conjunctival Melanoma Cells in Zebrafish Ectopic and Orthotopic Tumour Models](https://www.mdpi.com/cancers/cancers-12-00587/article_deploy/html/images/cancers-12-00587-g005b.png)
Cancers | Free Full-Text | TLD1433 Photosensitizer Inhibits Conjunctival Melanoma Cells in Zebrafish Ectopic and Orthotopic Tumour Models
![Transition Metal Complexes and Photodynamic Therapy from a Tumor-Centered Approach: Challenges, Opportunities, and Highlights from the Development of TLD1433. - Abstract - Europe PMC Transition Metal Complexes and Photodynamic Therapy from a Tumor-Centered Approach: Challenges, Opportunities, and Highlights from the Development of TLD1433. - Abstract - Europe PMC](https://europepmc.org/articles/PMC6453754/bin/nihms-996583-f0023.jpg)
Transition Metal Complexes and Photodynamic Therapy from a Tumor-Centered Approach: Challenges, Opportunities, and Highlights from the Development of TLD1433. - Abstract - Europe PMC
![Anticancer Photodynamic Therapy Using Ruthenium(II) and Os(II)-Based Complexes as Photosensitizers | IntechOpen Anticancer Photodynamic Therapy Using Ruthenium(II) and Os(II)-Based Complexes as Photosensitizers | IntechOpen](https://www.intechopen.com/media/chapter/68655/media/F4.png)
Anticancer Photodynamic Therapy Using Ruthenium(II) and Os(II)-Based Complexes as Photosensitizers | IntechOpen
![Transition Metal Complexes and Photodynamic Therapy from a Tumor-Centered Approach: Challenges, Opportunities, and Highlights from the Development of TLD1433 | Chemical Reviews Transition Metal Complexes and Photodynamic Therapy from a Tumor-Centered Approach: Challenges, Opportunities, and Highlights from the Development of TLD1433 | Chemical Reviews](https://pubs.acs.org/cms/10.1021/acs.chemrev.8b00211/asset/images/medium/cr-2018-00211x_0002.gif)
Transition Metal Complexes and Photodynamic Therapy from a Tumor-Centered Approach: Challenges, Opportunities, and Highlights from the Development of TLD1433 | Chemical Reviews
![Clinical Development of Metal Complexes as Photosensitizers for Photodynamic Therapy of Cancer - Karges - 2022 - Angewandte Chemie International Edition - Wiley Online Library Clinical Development of Metal Complexes as Photosensitizers for Photodynamic Therapy of Cancer - Karges - 2022 - Angewandte Chemie International Edition - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/61e3ad37-3f3b-4dd4-9fbd-e0b52bcf2e3f/anie202112236-fig-0005-m.jpg)
Clinical Development of Metal Complexes as Photosensitizers for Photodynamic Therapy of Cancer - Karges - 2022 - Angewandte Chemie International Edition - Wiley Online Library
![NAMI-A and KP1019/NKP1339 are ruthenium complexes that entered clinical... | Download Scientific Diagram NAMI-A and KP1019/NKP1339 are ruthenium complexes that entered clinical... | Download Scientific Diagram](https://www.researchgate.net/publication/332413404/figure/fig2/AS:782383733288960@1563546226015/NAMI-A-and-KP1019-NKP1339-are-ruthenium-complexes-that-entered-clinical-trials-NAMI-A.png)
NAMI-A and KP1019/NKP1339 are ruthenium complexes that entered clinical... | Download Scientific Diagram
![Cancers | Free Full-Text | TLD1433 Photosensitizer Inhibits Conjunctival Melanoma Cells in Zebrafish Ectopic and Orthotopic Tumour Models Cancers | Free Full-Text | TLD1433 Photosensitizer Inhibits Conjunctival Melanoma Cells in Zebrafish Ectopic and Orthotopic Tumour Models](https://www.mdpi.com/cancers/cancers-12-00587/article_deploy/html/images/cancers-12-00587-g001.png)
Cancers | Free Full-Text | TLD1433 Photosensitizer Inhibits Conjunctival Melanoma Cells in Zebrafish Ectopic and Orthotopic Tumour Models
![Theralase Technologies Inc seeks OK from Health Canada to start hase Ib clinical trial for the treatment of non-muscle invasive bladder cancer Theralase Technologies Inc seeks OK from Health Canada to start hase Ib clinical trial for the treatment of non-muscle invasive bladder cancer](https://www.proactiveinvestors.com//thumbs/upload/Article/Image/2016_07/1200z740_UrinaryBladder.jpg)
Theralase Technologies Inc seeks OK from Health Canada to start hase Ib clinical trial for the treatment of non-muscle invasive bladder cancer
![Clinical development and potential of photothermal and photodynamic therapies for cancer | Nature Reviews Clinical Oncology Clinical development and potential of photothermal and photodynamic therapies for cancer | Nature Reviews Clinical Oncology](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41571-020-0410-2/MediaObjects/41571_2020_410_Fig1_HTML.png)
Clinical development and potential of photothermal and photodynamic therapies for cancer | Nature Reviews Clinical Oncology
![Metal-based photosensitizers for photodynamic therapy: the future of multimodal oncology? - ScienceDirect Metal-based photosensitizers for photodynamic therapy: the future of multimodal oncology? - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1367593119301164-gr1.jpg)
Metal-based photosensitizers for photodynamic therapy: the future of multimodal oncology? - ScienceDirect
![Combining PARP Inhibition with Platinum, Ruthenium or Gold Complexes for Cancer Therapy - Yusoh - 2020 - ChemMedChem - Wiley Online Library Combining PARP Inhibition with Platinum, Ruthenium or Gold Complexes for Cancer Therapy - Yusoh - 2020 - ChemMedChem - Wiley Online Library](https://chemistry-europe.onlinelibrary.wiley.com/cms/asset/9ac2be7a-7e91-42db-8bce-32baba999b1d/cmdc202000391-fig-0003-m.jpg)
Combining PARP Inhibition with Platinum, Ruthenium or Gold Complexes for Cancer Therapy - Yusoh - 2020 - ChemMedChem - Wiley Online Library
![Transition Metal Complexes and Photodynamic Therapy from a Tumor-Centered Approach: Challenges, Opportunities, and Highlights from the Development of TLD1433. - Abstract - Europe PMC Transition Metal Complexes and Photodynamic Therapy from a Tumor-Centered Approach: Challenges, Opportunities, and Highlights from the Development of TLD1433. - Abstract - Europe PMC](https://europepmc.org/articles/PMC6453754/bin/nihms-996583-f0010.jpg)
Transition Metal Complexes and Photodynamic Therapy from a Tumor-Centered Approach: Challenges, Opportunities, and Highlights from the Development of TLD1433. - Abstract - Europe PMC
![Cancers | Free Full-Text | TLD1433 Photosensitizer Inhibits Conjunctival Melanoma Cells in Zebrafish Ectopic and Orthotopic Tumour Models Cancers | Free Full-Text | TLD1433 Photosensitizer Inhibits Conjunctival Melanoma Cells in Zebrafish Ectopic and Orthotopic Tumour Models](https://www.mdpi.com/cancers/cancers-12-00587/article_deploy/html/images/cancers-12-00587-g002.png)
Cancers | Free Full-Text | TLD1433 Photosensitizer Inhibits Conjunctival Melanoma Cells in Zebrafish Ectopic and Orthotopic Tumour Models
![Cancers | Free Full-Text | TLD1433 Photosensitizer Inhibits Conjunctival Melanoma Cells in Zebrafish Ectopic and Orthotopic Tumour Models Cancers | Free Full-Text | TLD1433 Photosensitizer Inhibits Conjunctival Melanoma Cells in Zebrafish Ectopic and Orthotopic Tumour Models](https://www.mdpi.com/cancers/cancers-12-00587/article_deploy/html/images/cancers-12-00587-g008.png)
Cancers | Free Full-Text | TLD1433 Photosensitizer Inhibits Conjunctival Melanoma Cells in Zebrafish Ectopic and Orthotopic Tumour Models
![Anticancer Photodynamic Therapy Using Ruthenium(II) and Os(II)-Based Complexes as Photosensitizers | IntechOpen Anticancer Photodynamic Therapy Using Ruthenium(II) and Os(II)-Based Complexes as Photosensitizers | IntechOpen](https://www.intechopen.com/media/chapter/68655/media/F1.png)
Anticancer Photodynamic Therapy Using Ruthenium(II) and Os(II)-Based Complexes as Photosensitizers | IntechOpen
![Transition Metal Complexes and Photodynamic Therapy from a Tumor-Centered Approach: Challenges, Opportunities, and Highlights from the Development of TLD1433 | Chemical Reviews Transition Metal Complexes and Photodynamic Therapy from a Tumor-Centered Approach: Challenges, Opportunities, and Highlights from the Development of TLD1433 | Chemical Reviews](https://pubs.acs.org/cms/10.1021/acs.chemrev.8b00211/asset/images/medium/cr-2018-00211x_0015.gif)